Saliva collection devices play an important role in the collection and storage of saliva samples for analysis. Saliva collection devices allow for easy, non-invasive collection and stabilization of DNA, RNA, proteins and other analytes from saliva samples. Saliva collection devices enable the collection of specimens for various applications including clinical diagnostics, forensic testing, drug testing and research applications. Saliva collection is a pain-free alternative to blood collection and has gained popularity in clinical testing for various disease conditions such as HIV, cancer and diabetes. With the rising focus on forensic applications of saliva tests, the demand for quality saliva collection devices has increased significantly.
The Global Saliva Collection Devices Market is estimated to be valued at US$ 342.46 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the Saliva Collection Devices are IBM Corporation, Oracle Corporation, Cerner Corporation, InterSystems Corporation, Allscripts Healthcare Solutions, Red Hat, Inc. (acquired by IBM), Microsoft Corporation, GE Healthcare, Infor, Inc., Epic Systems Corporation, TIBCO Software Inc., McKesson Corporation, Dell Technologies, Informatica Corporation, Ascom Holding AG. These players are focusing on new product launches and enhancing their product portfolio to gain more market share.
The increasing demand for home-based sample collection and non-invasive diagnostic procedures offer lucrative growth opportunities for players in the Saliva Collection Devices Market Size. The stress-free collection methodology and easy self-collection features of saliva collection devices are expected to drive their adoption in home care settings.
Globally, North America represents the largest market for saliva collection devices owing to rapid technological advancements and growing awareness regarding non-invasive diagnostic procedures. However, Asia Pacific is expected to witness the highest growth owing to rising geriatric population, increasing healthcare expenditure and growing focus on early disease diagnosis in countries such as China and India.
Market Drivers
The rising focus on forensic applications of saliva testing is a key driver boosting the saliva collection devices market. Saliva-based forensic tests provide a non-invasive method for DNA collection from suspects or individuals during criminal investigations. Saliva collection devices facilitate easy and reliable collection of samples for various forensic applications including personal identification, paternity testing and ancestry tracing. This is expected to significantly drive their demand from forensic laboratories and law enforcement agencies over the forecast period.
PEST Analysis
Political: Regulations like privacy acts and data protection laws can impact how patient data collected using saliva collection devices is used and shared. Governments may impose regulations around testing, storage and transportation of saliva samples.
Economic: Changes in GDP, healthcare spending and income levels affect demand for saliva collection devices from diagnostic labs and hospitals. Price points of these devices also determine their adoption rates.
Social: As non-invasive methods gain acceptance, demand is increasing for saliva-based tests for conditions like COVID-19 and cancer screening. aging populations need easy sample collection solutions. Lifestyle diseases have increased screening needs.
Technological: Advancements in material science led to improved collection tubes that stabilize samples at room temperature. Automation and digitalization help process volumes of samples with accuracy and efficiency. Connected devices enable remote monitoring use cases.
Geographical Regions with High Market Concentration
North America dominates the market currently due to established healthcare infrastructure, favorable reimbursement policies and widespread awareness. The United States accounts for the largest share due to availability of advanced technologies and large diagnostic industry.
Europe is the second major regional market led by Germany, United Kingdom and France. Growing focus on early detection of diseases and increasing researcher funding favors market growth.
Fastest Growing Region
The Asia Pacific region is projected to see the highest growth during the forecast period. This is attributed to rising healthcare expenditure, increasing awareness about saliva-based testing benefits and expanding med-tech industry in China, India and Japan. Governments prioritize improving access to affordable diagnostics.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it